Obesity is associated with decreased risk of microscopic colitis in women.


Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
14 Jan 2022
Historique:
received: 12 09 2021
revised: 18 10 2021
accepted: 31 12 2021
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 5 2 2022
Statut: ppublish

Résumé

Microscopic colitis is a leading cause of diarrhea in the older adults. There is limited information about risk factors. We hypothesized that obesity would be associated with microscopic colitis. To examine the association between obesity and microscopic colitis in men and women undergoing colonoscopy. We conducted a case-control study at the University of North Carolina Hospitals. We identified and enrolled men and women referred for elective, outpatient colonoscopy for chronic diarrhea. We excluded patients with a past diagnosis of Crohn's disease or ulcerative colitis. A research pathologist reviewed biopsies on every patient and classified them as microscopic colitis cases or non-microscopic colitis controls. Patients provided information on body weight, height and exposure to medications Cases were older and more likely than controls to be white race. Study subjects were well educated, but cases were better educated than controls. Cases with microscopic colitis had lower body mass index than controls and reported more weight loss after the onset of diarrhea. Compared to patients who were normal or under-weight, obese (BMI > 30 kg/m Compared to controls also seen for diarrhea, microscopic colitis cases were less likely to be obese. Mechanisms are unknown but could involve hormonal effects of obesity or the gut microbiome.

Sections du résumé

BACKGROUND BACKGROUND
Microscopic colitis is a leading cause of diarrhea in the older adults. There is limited information about risk factors. We hypothesized that obesity would be associated with microscopic colitis.
AIM OBJECTIVE
To examine the association between obesity and microscopic colitis in men and women undergoing colonoscopy.
METHODS METHODS
We conducted a case-control study at the University of North Carolina Hospitals. We identified and enrolled men and women referred for elective, outpatient colonoscopy for chronic diarrhea. We excluded patients with a past diagnosis of Crohn's disease or ulcerative colitis. A research pathologist reviewed biopsies on every patient and classified them as microscopic colitis cases or non-microscopic colitis controls. Patients provided information on body weight, height and exposure to medications
RESULTS RESULTS
Cases were older and more likely than controls to be white race. Study subjects were well educated, but cases were better educated than controls. Cases with microscopic colitis had lower body mass index than controls and reported more weight loss after the onset of diarrhea. Compared to patients who were normal or under-weight, obese (BMI > 30 kg/m
CONCLUSION CONCLUSIONS
Compared to controls also seen for diarrhea, microscopic colitis cases were less likely to be obese. Mechanisms are unknown but could involve hormonal effects of obesity or the gut microbiome.

Identifiants

pubmed: 35110947
doi: 10.3748/wjg.v28.i2.230
pmc: PMC8776530
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-241

Informations de copyright

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: Disclosures: None of the authors have financial, professional or personal conflicts of interest.

Références

Aliment Pharmacol Ther. 2012 Jul;36(2):79-90
pubmed: 22670660
Cell Host Microbe. 2017 Nov 8;22(5):589-599
pubmed: 29120742
Scand J Gastroenterol. 2018 Jun - Jul;53(7):818-824
pubmed: 29852792
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278
Pathol Eur. 1976;11(1):87-9
pubmed: 934705
J Crohns Colitis. 2018 Apr 27;12(5):559-567
pubmed: 29370359
Clin Gastroenterol Hepatol. 2015 Jun;13(6):1125-31
pubmed: 25616029
Scand J Gastroenterol. 2016 Oct;51(10):1206-12
pubmed: 27243102
Clin Pharmacol Ther. 2011 Jul;90(1):164-8
pubmed: 21633341
Clin Gastroenterol Hepatol. 2020 Apr;18(4):984-986
pubmed: 31254673
Curr Obes Rep. 2018 Dec;7(4):276-288
pubmed: 30155850
Clin Gastroenterol Hepatol. 2014 May;12(5):838-42
pubmed: 24120840
Linacre Q. 2017 Aug;84(3):275-295
pubmed: 28912620
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2523-2532.e1
pubmed: 30529732
Dig Dis Sci. 2017 Jun;62(6):1394-1395
pubmed: 28168580
Saudi J Gastroenterol. 2011 Nov-Dec;17(6):383-6
pubmed: 22064335
Aliment Pharmacol Ther. 2019 Jun;49(11):1395-1400
pubmed: 30983010
Gastroenterol Hepatol (N Y). 2014 Jul;10(7):411-6
pubmed: 25904828
Inflamm Bowel Dis. 2017 Jun;23(6):1040-1046
pubmed: 28471835
Am J Gastroenterol. 2015 May;110(5):749-59
pubmed: 25916221
Scand J Gastroenterol. 2013 Aug;48(8):944-50
pubmed: 23800241
J Crohns Colitis. 2020 Dec 2;14(12):1717-1723
pubmed: 32502240
J Neurogastroenterol Motil. 2021 Jul 30;27(3):314-325
pubmed: 33762473
Clin Gastroenterol Hepatol. 2021 Jun 30;:
pubmed: 34216819
Inflamm Bowel Dis. 2013 Feb;19(2):411-7
pubmed: 23344243
Front Horm Res. 2019;53:120-134
pubmed: 31499497
J Crohns Colitis. 2019 Dec 10;13(12):1578-1582
pubmed: 31125052
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1762-1767
pubmed: 29535059
J Physiol. 2009 Jul 1;587(Pt 13):3317-28
pubmed: 19433574
Cureus. 2020 May 13;12(5):e8094
pubmed: 32542149
Aliment Pharmacol Ther. 2021 Nov;54(9):1193-1201
pubmed: 34514632
J Clin Gastroenterol. 2017 Mar;51(3):228-234
pubmed: 27404403
Gastroenterology. 1980 Feb;78(2):264-71
pubmed: 7350049
Gastroenterology. 2018 Dec;155(6):1764-1775.e2
pubmed: 30144433
Scand J Gastroenterol. 2019 Apr;54(4):446-452
pubmed: 31009268
Scand J Gastroenterol. 1997 Sep;32(9):920-4
pubmed: 9299672
Drug Target Insights. 2013 Oct 07;7:53-62
pubmed: 24137050
Inflamm Bowel Dis. 2019 Mar 14;25(4):672-678
pubmed: 30869794
Clin Med Insights Gastroenterol. 2010 May 18;2010(3):11-19
pubmed: 20640056
United European Gastroenterol J. 2021 Feb 22;:
pubmed: 33619914
Fertil Steril. 2006 May;85(5):1319-40
pubmed: 16647374
World J Gastroenterol. 2015 Aug 7;21(29):8804-10
pubmed: 26269669
Dig Dis Sci. 2021 May 31;:
pubmed: 34059992
Eur J Clin Nutr. 2016 Nov;70(11):1309-1317
pubmed: 27460269

Auteurs

Robert S Sandler (RS)

Department of Medicine, University of North Carolina, Chapel Hill, NC 27514-7555, United States. rsandler@med.unc.edu.

Temitope O Keku (TO)

Department of Medicine, University of North Carolina, Chapel Hill, NC 27514-7555, United States.

John T Woosley (JT)

Department of Pathology, University of North Carolina, Chapel Hill, NC 27514, United States.

Dale P Sandler (DP)

Department of Health and Human Services, National Institute of Environmental Health Sciences, Durham, NC 27709, United States.

Joseph A Galanko (JA)

Department of Medicine, University of North Carolina, Chapel Hill, NC 27514-7555, United States.

Anne F Peery (AF)

Department of Medicine, University of North Carolina, Chapel Hill, NC 27514-7555, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH